Senate and House Democrats again attempt to expand fertility treatments for veterans and active-duty personnel; CDC expects high hospitalization numbers due to “tripledemic” of COVID-19, respiratory syncytial virus, and the flu; a study found that MDMA, also known as ecstasy, can reduce posttraumatic stress disorder (PTSD) symptoms.
Senate and House Democrats are trying again to expand fertility treatments for veterans and active-duty personnel whose military-related disabilities prevent them from conceiving without help, according to Military.com. After first attempting to do so in 2021, Sens Patty Murray (D, Washington) and Tammy Duckworth (D, Illinois), along with Rep Rick Larsen (D, Washington), plan to introduce bills for the second time that would cover fertility services for military family and veteran beneficiaries. These services would include allowing service members to freeze their gametes before deployment to a hazardous assignment and after injury or illness. It would also include making military and veteran spouses, parents, and surrogates eligible for reproductive technology treatments and expand adoption assistance to the Department of Veterans Affairs.
The CDC said on Thursday that it expects hospitalization numbers due to the “tripledemic” of COVID-19, respiratory syncytial virus (RSV), and the flu to be similar to those of last year, which were higher than prepandemic levels, according to Reuters. Flu and RSV infections are expected to increase over the fall and winter months, but vaccines for all 3 viruses will be available this fall to protect against them. The CDC noted that higher vaccination levels across the population will help reduce hospitalization numbers and the risk of putting strain on hospitals across the nation. To aid in the reduction, the CDC recently signed off on the broad use of updated COVID-19 vaccines from Moderna, Pfizer, and BioNTech SE that cover those 6 months and older in preparation for the country’s vaccine campaign.
A study found that the psychedelic drug 3,4-methylenedioxy-methamphetamine (MDMA, also known as ecstasy) can reduce posttraumatic stress disorder (PTSD) symptoms, according to the Associated Press. The study measured symptoms in 104 people with PTSD who all received talk therapy and were randomly assigned to take either MDMA or a placebo during 3 sessions, each 1 month apart. The researchers found that, by the end of the study, 72% of the MDMA group no longer met the diagnostic criteria for PTSD in comparison to about 48% of the placebo group. The company that sponsored the research said it plans to seek approval to market MDMA as a PTSD treatment when combined with talk therapy, but it first must receive approval from the FDA and have its classification changed by the Drug Enforcement Administration.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Medicaid, Medicare Policy Changes Could Lead to More Than 25,000 Additional Deaths, Study Says
April 30th 2024Researchers also estimated that more than 700,000 Americans with diabetes could lose insurance coverage if these proposed retractions are put into place, with some new policies already in effect.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More